These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 2777907)
1. Molecular modeling in the design of phospholipase A2 inhibitors. Ripka WC; Sipio WJ; Galbraith WG J Cell Biochem; 1989 Jul; 40(3):279-86. PubMed ID: 2777907 [TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of conformationally restricted phospholipids as phospholipase A2 inhibitors. Magolda RL; Galbraith W J Cell Biochem; 1989 Jul; 40(3):371-86. PubMed ID: 2777909 [TBL] [Abstract][Full Text] [Related]
3. Semisynthesis of phospholipase A2. The effect of substitution of amino-acid residues at positions 6 and 7 in bovine and porcine pancreatic phospholipases A2 on catalytic and substrate-binding properties. van Scharrenburg GJ; Puijk WC; de Haas GH; Slotboom AJ Eur J Biochem; 1983 Jun; 133(1):83-9. PubMed ID: 6852036 [TBL] [Abstract][Full Text] [Related]
4. Reaction of Woodward's Reagent K with pancreatic porcine phospholipase A2: modification of an essential carboxylase residue. Dinur D; Kantrowitz ER; Hajdu J Biochem Biophys Res Commun; 1981 May; 100(2):785-92. PubMed ID: 7271782 [No Abstract] [Full Text] [Related]
5. Inhibition of porcine pancreas phospholipase A2 activation by gabexate mesilate. Schädlich HR; Büchler M; Beger HG Klin Wochenschr; 1989 Feb; 67(3):160-2. PubMed ID: 2494376 [TBL] [Abstract][Full Text] [Related]
6. Competitive inhibition of lipolytic enzymes. III. Some acylamino analogues of phospholipids are potent competitive inhibitors of porcine pancreatic phospholipase A2. de Haas GH; Dijkman R; van Oort MG; Verger R Biochim Biophys Acta; 1990 Mar; 1043(1):75-82. PubMed ID: 2310763 [TBL] [Abstract][Full Text] [Related]
7. Identification of a specific region of low molecular weight phospholipases A2 (residues 21-40) as a potential target for structure-based design of inhibitors of these enzymes. Cordella-Miele E; Miele L; Mukherjee AB Proc Natl Acad Sci U S A; 1993 Nov; 90(21):10290-4. PubMed ID: 7694288 [TBL] [Abstract][Full Text] [Related]
8. Structure of porcine pancreatic phospholipase A2 at 2.6 A resolution and comparison with bovine phospholipase A2. Dijkstra BW; Renetseder R; Kalk KH; Hol WG; Drenth J J Mol Biol; 1983 Jul; 168(1):163-79. PubMed ID: 6876174 [TBL] [Abstract][Full Text] [Related]
9. Synthetic peptide from lipocortin I has no phospholipase A2 inhibitory activity. van Binsbergen J; Slotboom AJ; Aarsman AJ; de Haas GH FEBS Lett; 1989 Apr; 247(2):293-7. PubMed ID: 2523817 [TBL] [Abstract][Full Text] [Related]
10. Design of specific peptide inhibitors of phospholipase A2: structure of a complex formed between Russell's viper phospholipase A2 and a designed peptide Leu-Ala-Ile-Tyr-Ser (LAIYS). Chandra V; Jasti J; Kaur P; Dey S; Srinivasan A; Betzel Ch; Singh TP Acta Crystallogr D Biol Crystallogr; 2002 Oct; 58(Pt 10 Pt 2):1813-9. PubMed ID: 12351825 [TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of some substrate analogue inhibitors of phospholipase A2 and investigations by NMR and molecular modeling into the binding interactions in the enzyme-inhibitor complex. Bennion C; Connolly S; Gensmantel NP; Hallam C; Jackson CG; Primrose WU; Roberts GC; Robinson DH; Slaich PK J Med Chem; 1992 Aug; 35(16):2939-51. PubMed ID: 1501221 [TBL] [Abstract][Full Text] [Related]
12. The amino acid sequence of the phospholipase A2 isoenzyme from porcine pancreas. Puijk WC; Verheij HM; Wietzes P; de Haas GH Biochim Biophys Acta; 1979 Oct; 580(2):411-5. PubMed ID: 518908 [TBL] [Abstract][Full Text] [Related]
14. Structure of an engineered porcine phospholipase A2 with enhanced activity at 2.1 A resolution. Comparison with the wild-type porcine and Crotalus atrox phospholipase A2. Thunnissen MM; Kalk KH; Drenth J; Dijkstra BW J Mol Biol; 1990 Nov; 216(2):425-39. PubMed ID: 2254938 [TBL] [Abstract][Full Text] [Related]
15. Effects of the serine protease inhibitor gabexate mesilate on purified pancreatic phospholipase A2. Hesse B; Lankisch PG; Kunze H Pharmacol Res Commun; 1984 Jul; 16(7):637-45. PubMed ID: 6433363 [TBL] [Abstract][Full Text] [Related]
16. Specific competitive inhibitor of secreted phospholipase A2 from berries of Schinus terebinthifolius. Jain MK; Yu BZ; Rogers JM; Smith AE; Boger ET; Ostrander RL; Rheingold AL Phytochemistry; 1995 Jun; 39(3):537-47. PubMed ID: 7576451 [TBL] [Abstract][Full Text] [Related]
17. 1H-NMR and protection studies of interactions between ligands and bovine pancreatic phospholipase A2. Williamson MP; Davis PD; Broadhurst MJ; Nixon JS Biochim Biophys Acta; 1989 Jul; 997(1-2):9-14. PubMed ID: 2752056 [TBL] [Abstract][Full Text] [Related]
18. Are phospholipid-binding proteins in vivo phospholipase inhibitors? Poensgen J Klin Wochenschr; 1989 Feb; 67(3):163-5. PubMed ID: 2494377 [TBL] [Abstract][Full Text] [Related]
19. Effects of substitution of the absolutely invariant glutamine-4 and phenylalanine-5 in bovine pancreatic phospholipase A2 on enzymatic activity and substrate binding properties. van Scharrenburg GJ; Puijk WC; Egmond MR; van der Schaft PH; de Haas GH; Slotboom AJ Biochemistry; 1982 Mar; 21(6):1345-52. PubMed ID: 7074092 [No Abstract] [Full Text] [Related]
20. Crystal structure of a porcine pancreatic phospholipase A2 mutant. A large conformational change caused by the F63V point mutation. Thunnissen MM; Franken PA; de Haas GH; Drenth J; Kalk KH; Verheij HM; Dijkstra BW J Mol Biol; 1993 Aug; 232(3):839-55. PubMed ID: 8355274 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]